VH-298

VH-298
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-TQ0121-2mg 2 mg

7 - 10 business days*

40.00€
TGM-TQ0121-5mg 5 mg

7 - 10 business days*

72.00€
TGM-TQ0121-1mL 1 ml

7 - 10 business days*

83.00€
TGM-TQ0121-10mg 10 mg

7 - 10 business days*

120.00€
TGM-TQ0121-25mg 25 mg

7 - 10 business days*

228.00€
TGM-TQ0121-50mg 50 mg

7 - 10 business days*

371.00€
TGM-TQ0121-100mg 100 mg

7 - 10 business days*

621.00€
 
Description: VH-298 is a potent inhibitor of VHL that stabilizes HIF-alpha and elicits a hypoxic... more
Product information "VH-298"
Description: VH-298 is a potent inhibitor of VHL that stabilizes HIF-alpha and elicits a hypoxic response via a different mechanism, that is the blockade of the VHL:HIF-alpha protein-protein interaction downstream of HIF-alpha hydroxylation by PHD enzymes. Target: HIF, Ligand for E3 Ligase, Others. Smiles: Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(CC2)C#N)C(C)(C)C)cc1. References: Frost J, et al. Potent and selective chemical probe of hypoxic signalling downstream of HIF-alpha hydroxylation via VHL inhibition. Nat Commun. 2016 Nov 4,7:13312.
Supplier: TargetMol
Supplier-Nr: TQ0121

Properties

Application: Protac(R) reagent
MW: 523.65 D
Formula: C27H33N5O4S

Database Information

CAS : 2097381-85-4| Matching products
KEGG ID : K03871 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "VH-298"
Write a review
or to review a product.
Viewed